Technological Institute of the PhilippinesChemical Engineering Department

Joshua Peter E. Cadoy5th Year – BS Chemical EngineeringCHEP582 Laws and Ethics for Chemical Engineers

Department of Trade and Industry (DTI)

Gregory L. Domingo, DTI Secretary

Josephine C. Romero, DTI Assistant Secretary/Chief of Staff

Armando Q. Mercado, Jr., Head Executive Assistant

Letty C. Caoile, DTI Assistant to the Secretary

Eduardo M. Ocol, DTI Assistant to the Secretary

Nennette B. Pelagio, DTI Appointments Secretary

Maria Lourdes A. Yaptinchay, E-Commerse Office Director

Maria Crispina S. Reodica, E-Commerse Chief

Abigail R. Zurita, Liaison Office for Legislative Affairs Officer‐in‐Charge

Alfonso M. Valenzuela, Liaison Office for Legislative Affairs Information Officer

Atty. Benjamin T. Subido, Office of Legal Affairs Director

Atty. Rodolfo B. Gilbang, Office of Legal Affairs Chief, Administrative Adjudication & Investigation Division

Atty. Marimel D. Porciuncula, Office of Legal Affairs Chief, Counseling & Litigation Division

Maria Lourdes A. Yaptinchay, Office of Policy Research Director

Thelma Dumpit‐Murillo, Public Relations Office Director IV

Lydia R. Guevarra, Office of Special Concerns Director

Bureau of Food and Drugs (BFAD) / Food and Drugs Administration (FDA)

Kenneth Hartigan-Go, FDA Acting Director

Dr. Oscar Gutierrez Jr., FDA food and drug regulation officer

Bureau of Customs

Rozzano Rufino B. Biazon, Commissioner of Customs

Juan Lorenzo T. Tañada, Internal Administration Group Deputy Commissioner

Prudencio M. Reyes, Jr., Assessment & Operations Coordinating Group Deputy Commissioner

Peter M. Manzano, Revenue Collection Monitoring Group Deputy Commissioner

Danilo D. Lim, Intelligence Group Deputy Commissioner

Horacio P. Suansing Jr., Enforcement Group Deputy Commissioner

Ma. Caridad P. Manarang, Management Information System and Technology Group Deputy Commissioner

Ericson A. Alcovendaz, Post Entry Audit Group Assistant Commissioner

Ma. Lourdes V. Mangaoang, X-Ray Inspection Project Head

Wilnora L. Cawile, Interim Internal Control Division Chief

Department of Health (DOH)

Dr. Enrique T. Ona, Secretary of Health

Dr. David J. Lozada, Jr., Undersecretary of Health

Dr. Nemesio T. Gako, Administration Technical Cluster Undersecretary of Health

Dr. Teodoro J. Herbosa, Area Cluster Undersecretary for Ncr And Southern Luzon Undersecretary of

Health

Dr. Gerardo V. Bayugo, Area Cluster Assistant Secretary for Northern and Central Luzon Undersecretary of

Health Designate

Dr. Elmer G. Punzalan, Office for Special Concerns Assistant Secretary of Health

Dr. Paulyn Jean B. Rosell-Ubial, Area Cluster Assistant Secretary for Visayas Assistant Secretary of Health

Dr. Madeleine R. Valera, Health Policy Finance and Research Development Cluster Assistant Secretary of

Health

Dr. Enrique A. Tayag, Support to Service Delivery Technical Cluster II Assistant Secretary of Health

Designate

Dr. Romulo A. Busuego, Area Cluster Assistant Secretary for Mindanao Assistant Secretary of Health

Designate

Dr. Roland L. Cortez, Support to Service Delivery Technical Cluster I Assistant Secretary of Health

Designate

Ms. Blesilda A. Gutierrez, Internal Finance Management Technical Cluster Assistant Secretary of Health

Designate

Dr. Jaime Y. Lagahid, Director III (NCDPC-IDO); Head Executive Assistant

Dr. Kadil M. Sinolinding, Department of Health - Autonomous Region for Muslim Mindanao Secretary of

Health

Atty. Nicolas B. Lutero III, Support to Service Delivery Cluster III Assistant Secretary of Health Designate

How to recall products in manufacturing company

Despite a company's best efforts to design, manufacture and sell safe and reliable products, the possibility

still exists that dangerously defective products may reach the customers. These products may cause

accidents, leading to adverse verdicts in product liability litigations. Unfavorable publicity may result in loss

of sales and damage to the company's reputation.

Recalls are actions taken by a firm to remove a product from the market. Recalls may be conducted on a

firm's own initiative, by FDA request, or by FDA order under statutory authority.

If a product is recalled, it must be removed from store shelves, but often recalled products can still be found

on the second-hand market or in homes.

Unless appropriate action is taken promptly, these defective products may pose a severe financial threat to

the company and can have a very serious financial impact on the company forbears to come.

The very survival of a firm may depend on how well and how quickly it can respond to the first notice that a

product recall may be necessary. Product recalls are certainly expensive, but attempting them without

adequate planning can be much more costly.

Depending on the seriousness of the situation, the company may have a choice whether to repair or modify

the product (no cost or reduced cost retrofit by customer or the company), refund the purchase price, or

initiate a total or partial recall (voluntary or mandatory).

In case of a mandatory recall, the company can contest the notice of recall from a regulatory agency. This

should be done only after a thorough review of the situation and with appropriate legal counsel.

A company that undertakes a recall should develop a comprehensive plan that reaches throughout the

entire distribution chain to consumers who have the product. The company must design each

communication to reach affected consumers, motivate people to respond to the recall and take the action

requested by the company.

Once the staff and a company agree on a remedy to correct a product defect, the staff works with the

company to put together an effective plan for public notification and implementation of the recall. The

information should be included in a corrective action plan (“CAP”).

Administration and Coordination: The recall plan must have the endorsement of top management, and it

should assign responsibility and authority for the decision to recall or fields modify a product to a specific

executive officer of the company.

The standby recall should also outline the coordination of the program, for example, coordination may rest

with the product safety/liability coordinator at the corporate, plant or division level.

Other elements of the recall plan should include:

• Analysis of the seriousness of the reported safety hazards and recommended appropriate action.

• Notification of recall to the appropriate regulatory agency, if required.

• Coordination of internal activities/procedures for all personnel who may be involved in the recall,

including the Communication Department to acquaint them with the plan and to draft needed

announcements.

Training and duties and responsibilities in the event of a recall should also be outlined.

• Liaison (notification, cooperation, and assistance) with dealers, distributors, wholesalers, and retailers

about prearranged procedures and fees for essential services, including collection, storage retrofit,

and/or disposal of recalled items.

• Provision of publicity and damage control, through letters and telegrams to all traceable customers,

and press releases to the media, to ensure that the situation is presented in a positive manner that will

reduce negative perceptions.

• Notification of recall to the insurance company.

• Monitoring and appropriate corrective actions.